Sarah Bast has spent much of her career studying a peculiar problem: an important message can be accurate, beautifully made and delivered to the right person, yet still arrive at the wrong moment. In ordinary advertising, that is wasteful. In pharmaceutical media, where a provider may be considering options and a patient may be preparing for a conversation, timing is part of the message itself.
In July 2026, Bast changed her own timing. After 18 years at Publicis Health Media, the Philadelphia-based executive joined OptimizeRx as chief marketing officer. She had spent years advising brands, assessing media partners and building specialist practices from the agency side. Now she would help shape a healthcare technology company from the inside, leading its marketing strategy, brand position and route to market.
It was a move from buyer to builder, though “translator” may be the more useful word. Bast speaks the languages of agencies, pharmaceutical brands, media sellers and technology teams. Her new task is to make those groups sound less like an unruly conference call and more like a coordinated plan.
A career that started where attention is loud
Before healthcare media, Bast worked near spectacle. Her early résumé includes NBC Olympics, the New York Knicks and Madison Square Garden, plus national and regional promotions at Universal Orlando Resort. At Penn State’s Schreyer Honors College, where she studied recreation and park management with a business marketing minor, she was also a Blue Band majorette and participated in THON as a morale-team member and dancer. A 2000 Olympics study-abroad program at the University of New South Wales added Sydney to the education.
The settings sound distant from electronic health records and media measurement. Yet they share a grammar: audience, sequence, anticipation, cue. A sporting event works because hundreds of moving pieces agree on the moment. Marketing works when fewer pieces manage the same courtesy.
Bast moved into pharmaceutical communications at Bristol Myers Squibb, then developed media experience at MS3 and MediaCom. Roles at Digitas Health and Razorfish Health followed. Each stop brought her closer to a field whose complexity tends to reproduce overnight. New screens appear. New data grows around them. Another acronym walks into the meeting and asks for a chair.
At Publicis Health Media, she rose from vice president to group vice president, then senior vice president and executive vice president. She helped develop specialist capabilities in point-of-care media and electronic health records, later overseeing investment strategy and innovation that also included telehealth partnerships. Her client work touched companies including Eli Lilly, Bayer, Johnson & Johnson and AstraZeneca.
Moves from sports and entertainment promotions into pharmaceutical communications and media.
Builds an 18-year Publicis Health Media career, rising through four executive levels.
Receives the Healthcare Businesswomen’s Association Rising Star honor.
Serves on the Point of Care Marketing Association board and wins three consecutive terms.
Joins OptimizeRx as chief marketing officer.
That progression matters because Bast’s public arguments rarely treat media as a decoration added after strategy. In a 2019 article, she wrote that digitization was changing where, when and how people received care, while point-of-care marketing had not yet caught up. By 2025, her interviews were focused on addressable video, deduplicated reach, interactive connected television and independent measurement. The channel list grew. Her question stayed stubbornly practical: did the plan help move somebody toward useful action?
“Reach and impressions still have a role, but they are not the end goal.”Sarah Bast, 2026
The doctor’s office is a place. The decision is a journey.
The phrase “point of care” invites a pin on a map: an exam room, pharmacy counter or electronic record. Bast’s more recent definition is temporal. Point of care is the moment when a provider is evaluating an option, when a patient is preparing to ask a question, or when either needs support for the next step. Place still matters. Moment explains why.
This shift rearranges the media plan. Traditional organizations often develop provider and patient campaigns separately, with different budgets, partners and scorecards. The administrative boxes are neat; the lived journey is not. A provider and a patient participate in the same decision, so messages that ignore each other can produce repetition, contradiction or simply noise.
At OptimizeRx, Bast sees an opportunity to connect these worlds with clinical context, privacy-conscious audience intelligence and coordinated activation across channels. This is not a plea to stuff one more ad into a crowded day. Her stated test is almost editorial: every message should have utility in the exact moment it appears.
Utility is a severe little word. It makes a campaign defend its existence. A million impressions can look handsome in a report; usefulness asks what happened next. Did information support a productive conversation? Did it reduce a practical obstacle? Did it make a decision easier to navigate? Bast wants the measurement framework to approach those questions, not stop at the comforting arithmetic of delivery.
An optimizer who asks for a referee
Bast’s 2025 discussion of video offers a glimpse of her operating style. She talked about addressable tools that could reduce duplicated audiences and manage frequency, then insisted on outside measurement. Audience quality, cost efficiency and performance needed independent validation. The marketer may plan the match, but she should not also appoint herself referee.
Her examples moved easily between mass culture and individual action. A campaign around a televised event could continue through online video, social media and point-of-care placements. Connected television could turn a pause screen into an invitation to learn more. None of these devices mattered alone. Planning linked them; live information helped adjust them; measurement decided what deserved to continue.
Channels should inherit a common strategy rather than behave like separate campaigns.
Provider and patient communication should reinforce the same decision process.
Independent partners can test audience quality, efficiency and results.
Timing and practical utility matter more than another appearance on a dashboard.
There is a community version of this impulse, too. Bast’s public profile lists board service with the Point of Care Marketing Association, including three consecutive elected terms, as well as earlier work on its Industry Advisory Council. She has served the Philadelphia Interactive Marketing Association and the Healthcare Businesswomen’s Association. Outside the trade, she has been a youth softball coach and commissioner, a Girl Scouts troop helper and a Girls on the Run coach.
It is tempting to over-polish these details into a leadership parable. Better to notice the plain connection: teams require systems, and systems require people willing to do the unglamorous coordinating. A board needs consensus. A media plan needs measurement. A softball league needs somebody to work out who plays where on Tuesday.
Crossing the table
Bast joined OptimizeRx at a moment when the company was expanding its portfolio across point-of-care technology and coordinated provider and consumer engagement. From the outside, she had spent years deciding which partners understood marketers’ problems and which merely understood their own sales deck. From the inside, she can now bring that buyer’s memory into positioning, products and partnerships.
She has described the appeal as a chance to simplify complexity and build around problems marketers are actually trying to solve. The ambition is less a new campaign than a new choreography. Clinical signals, audience intelligence, electronic records and broader media can work together, provided someone resists the industry’s habit of mistaking accumulation for progress.
“The future is synchronized.”Sarah Bast, on connecting patient and provider communication
Her first months as CMO have made the thesis explicit. She wants success to mean more than exposure. She wants provider information delivered without unnecessary disruption, patient communication that helps clarify a path, and brand teams able to see how investment contributes to an outcome. The phrase she uses for the desired future is “more connected, more useful, and more human.”
The last adjective keeps the first two honest. Connection without judgment produces more alerts. Usefulness without empathy becomes an efficient nuisance. Bast’s career has been a long education in the distance between reaching an audience and deserving its attention. Her new role gives her a chance to close some of that distance.
A good point-of-care message may be nearly invisible as marketing. It appears when it belongs, supports what happens next and then gets out of the way. That is a modest aesthetic for an industry fond of scale. It is also a demanding one. Timing must be right, data handled responsibly, channels coordinated and results tested. Spectacle was where Bast began. Precision is where she has arrived.